A novel vaccine against Neisseria gonorrhoeae
Neisseria gonorrhoeae vaccine using outer membrane vesicles (OMVs) derived from a genetically modified strain of Neisseria.
A new strain of gonococcus, produced by replacing the native PorB with analogs from another bacterium to enhance immunogenicity, as new generation outer membrane vesicle (OMV) vaccine.
Applications: Vaccines
| Features | Benefits |
|---|---|
| Simple replacement of Neisseria gonorrhaeae porB gene with Neisseria Meningitidis porB gene | Enhances immunogenicity whilst maintains viability of Neisseria gonorrhoeae |
| §Deletion of RmpM gene | Increases OMV production which is a key component of OMV vaccines |
Patented and Available For
- Co-development
- Consulting
- Licensing